Literature DB >> 11007784

Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells.

K Pruitt1, R G Pestell, C J Der.   

Abstract

Although Ras and Raf cause transformation of NIH 3T3 fibroblasts, only Ras causes transformation of RIE-1 intestinal epithelial cells. To determine if the inability of Raf to transform RIE-1 cells is due to a failure to deregulate cell cycle progression, we evaluated the consequences of sustained Ras and Raf activation on steady state levels of cyclin D1, p21(CIP/WAF), and p27(KIP1). Both Ras- and Raf-transformed NIH 3T3 cells showed up-regulated expression of cyclin D1, p21, and p27 protein, increased retinoblastoma (Rb) hyperphosphorylation, and increased activation of E2F-mediated transcription. Similarly, Ras-transformed RIE-1 cells also showed up-regulation of cyclin D1, p21, and hyperphosphorylated Rb. In contrast, Ras-mediated down-regulation of p27 was seen in RIE-1 cells. Conversely, stable expression of activated Raf alone caused only a partial up-regulation of p21 and Rb hyperphosphorylation but no activation of E2F-responsive transcription or down-regulation of p27 in RIE-1 cells. Moreover, we found that the AP-1 site was dispensable for Ras-mediated stimulation of the cyclin-D1 promoter in NIH 3T3 cells but was essential for Ras-mediated stimulation in RIE-1 cells. Thus, up-regulation of p21, rather than the down-regulation seen in previous transient expression studies, is seen with sustained Ras activation. Additionally, p27 may serve a positive (NIH 3T3) or negative (RIE-1) regulatory role in Ras transformation that is cell type-dependent. The involvement of Raf and phosphatidylinositol 3-kinase in mediating Ras changes in cyclin D1, p21, and p27 was also very distinct in NIH 3T3 and RIE-1 cells. Taken together, these results demonstrate the importance of Raf-independent pathways in mediating oncogenic Ras deregulation of cell cycle progression in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11007784     DOI: 10.1074/jbc.M006682200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.

Authors:  Piyali Dasgupta; Jiazhi Sun; Sheng Wang; Gina Fusaro; Vicki Betts; Jaya Padmanabhan; Saïd M Sebti; Srikumar P Chellappan
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

2.  Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.

Authors:  Franck Amblard; Baskaran Govindarajan; Benjamin Lefkove; Kimberly L Rapp; Mervi Detorio; Jack L Arbiser; Raymond F Schinazi
Journal:  Bioorg Med Chem Lett       Date:  2007-06-10       Impact factor: 2.823

3.  Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.

Authors:  Sushil G Rane; Stephen C Cosenza; Richard V Mettus; E Premkumar Reddy
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling.

Authors:  Shiri Kfir; Marcelo Ehrlich; Ayelet Goldshmid; Xuedong Liu; Yoel Kloog; Yoav I Henis
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Ecdysone-inducible expression of oncogenic Ha-Ras in NIH 3T3 cells leads to transient nuclear localization of activated extracellular signal-regulated kinase regulated by mitogen-activated protein kinase phosphatase-1.

Authors:  David Plows; Paraskevi Briassouli; Carolyn Owen; Vassilis Zoumpourlis; Michelle D Garrett; Alexander Pintzas
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

Review 6.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

7.  In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors.

Authors:  Natalia Skobeleva; Sanjay Menon; Lutz Weber; Erica A Golemis; Vladimir Khazak
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261

8.  Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.

Authors:  Kevin Pruitt; Rebekah L Zinn; Joyce E Ohm; Kelly M McGarvey; Sung-Hae L Kang; D Neil Watkins; James G Herman; Stephen B Baylin
Journal:  PLoS Genet       Date:  2006-03-31       Impact factor: 5.917

9.  Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition.

Authors:  Ariella B Hanker; Kevin D Healy; Jean Nichols; Channing J Der
Journal:  J Mol Signal       Date:  2009-08-16

10.  Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling.

Authors:  Na Guo; Zuojia Liu; Wenjing Zhao; Erkang Wang; Jin Wang
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.